Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Roland Skinner

Neurology Florence, SC Medical Doctor

NPI 1104993807 CMS profile 186898

800 E Cheves St, Suite 380, Florence, SC 29506

Open in the dashboard

General payments

$2,399

155 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Roland Skinner of Florence, SC is reported in the CMS Open Payments database as having received $2,399 across 155 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 57th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $602 32
2021 General $480 36
2020 General $204 13
2019 General $1,112 74

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Roland Skinner
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Roland Skinner were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Roland Skinner Neurology median Middle half National median
2019 $1,112 $474 $118–$2,177 $163
2020 $204 $367 $82–$2,309 $114
2021 $480 $438 $104–$2,547 $132
2022 $602 $442 $103–$2,388 $149
2023 $0 $464 $119–$2,312 $160
2024 $0 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Teva Pharmaceuticals USA, Inc. $375 27 payments
  2. AbbVie, Inc. $189 19 payments
  3. ACADIA Pharmaceuticals Inc $167 9 payments
  4. Novartis Pharmaceuticals Corporation $156 11 payments
  5. Biogen, Inc. $125 8 payments
  6. Supernus Pharmaceuticals, Inc. $106 5 payments
  7. EMD Serono, Inc. $98 7 payments
  8. Janssen Pharmaceuticals, Inc $85 4 payments
  9. Biohaven Pharmaceutical Holding Company Ltd. $83 5 payments
  10. Amgen Inc. $80 4 payments
  11. Other $935 56 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Food and Beverage $2,368 153 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $31 2 payments
Products named General payments · program years 2019–2022
  1. UBRELVY $178 18 payments
  2. Ajovy Central Nervous System $157 13 payments
  3. NUPLAZID $148 8 payments
  4. AJOVY Central Nervous System $146 9 payments
  5. AIMOVIG $121 8 payments
  6. TYSABRI $112 7 payments
  7. TECFIDERA $100 7 payments
  8. NURTEC ODT $95 6 payments
  9. Ponvory $85 4 payments
  10. TROKENDI XR $82 4 payments
  11. Other $1,591 96 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

155 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record